The incidence of digoxin toxicity among patients in hospitals has decl
ined in recent years. To evaluate whether a similar decline has occurr
ed in ambulatory care, we reviewed randomly selected medical records f
or 183 outpatients receiving ongoing treatment with digoxin at 10 urba
n and rural Department of Veterans Affairs medical Centers in the Rock
y Mountain region. The prevalence of traditional risk factors for digo
xin toxicity-elevated serum digoxin and serum creatinine levels, hypok
alemia, and a new prescription of an interacting drug-was established
from compsuterized laboratory and pharmacy records. Of the 183 patient
s, 50 (27.3%) had one or more risk factors for digoxin toxicity: serum
digoxin levels were elevated in 13.6% of patients in whom a level was
obtained, with hypokalemia in 14.3%, elevated creatinine levels in 17
.9%, and possible drug interactions in 5.5% of patients over a 1-year
period. Nevertheless, digoxin toxicity occurred in only 2 persons (1.1
% or 1.4 per 100 patient-years of treatment). We conclude that digoxin
toxicity was rare in this group of outpatients, even in persons presu
med to be at high risk because of metabolic abnormalities, increased d
igoxin concentrations, or the use of interacting drugs. The low rate o
f digoxin toxicity in outpatients parallels the decline in the inciden
ce of toxicity observed in hospital-based studies.